Seizure Burden After Critical Systemic Injury: A Comprehensive Review for Clinicians

Abstract

Seizures are a significant complication following critical systemic injuries, contributing to increased morbidity and mortality in affected patients. This review synthesizes current knowledge on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic strategies, therapeutic approaches, recent advances, and guideline recommendations regarding seizure burden after critical systemic insults. Emphasis is placed on evidence-based management and clinically relevant insights to inform practice in intensive care and neurocritical settings.

Introduction

Critical systemic injuries, such as traumatic brain injury (TBI), sepsis, multi-organ failure, and major cardiovascular events, frequently predispose patients to acute symptomatic seizures and, in some cases, status epilepticus. These neurological events can adversely impact patient outcomes, prolong hospitalizations, and complicate recovery trajectories. Understanding the mechanisms, risk stratification, and evidence-based approaches to seizure management is vital for clinicians caring for these vulnerable populations.

Epidemiology / Disease Burden

Seizures occur in up to 10-25% of patients with severe systemic insults, with higher rates observed in those with direct central nervous system involvement. Critically ill patients, especially those in intensive care units (ICUs), exhibit a heightened risk for both clinical and subclinical (nonconvulsive) seizures, the latter being detectable only through continuous electroencephalographic (EEG) monitoring. Studies highlight that post-injury seizures are associated with increased mortality, longer ICU stays, and poorer neurological outcomes, thereby representing a substantial disease burden globally.

Pathophysiology

The mechanisms underpinning seizure generation after critical systemic injury are multifactorial. Systemic inflammatory responses, blood-brain barrier disruption, metabolic derangements (including hypoxia, hypoglycemia, and electrolyte imbalance), and direct neuronal injury all play contributory roles. Proinflammatory cytokines and neurotoxins generated in sepsis or multi-organ dysfunction can lower the seizure threshold. In TBI and cardiac arrest, secondary cerebral insults such as ischemia-reperfusion injury further exacerbate neuronal excitability, predisposing to epileptogenesis.

Risk Factors

A range of patient- and injury-related risk factors increase the likelihood of seizures following critical systemic insult. Patient factors include advanced age, pre-existing neurological disorders, and genetic susceptibility. Injury characteristics such as severity of insult, presence of intracranial hemorrhage, hypoxic-ischemic injury, and prolonged hypotension are particularly significant. Iatrogenic factors, including certain medications (e.g., antibiotics, immunosuppressants), and metabolic disturbances also elevate seizure risk. Recognizing these factors facilitates early identification and preventative strategies in high-risk cohorts.

Clinical Features

Seizures in the critically ill may present with overt convulsive activity or, more commonly, with subtle or nonconvulsive manifestations such as altered consciousness, involuntary motor phenomena, or unexplained fluctuations in neurological status. Nonconvulsive status epilepticus (NCSE) is especially prevalent and often underdiagnosed without EEG monitoring. Clinical vigilance is required, as unrecognized seizures can lead to progressive neuronal injury and secondary brain damage.

Diagnosis

Diagnosis of seizures following systemic injury relies on a combination of clinical assessment and neurophysiological monitoring. Continuous or prolonged EEG is the gold standard for detecting both convulsive and nonconvulsive seizures, particularly in comatose or sedated patients. Neuroimaging (CT, MRI) may reveal acute cerebral insults or structural lesions predisposing to seizures. Laboratory evaluation is essential to identify and correct metabolic, toxic, or infectious precipitants. Early and accurate diagnosis is pivotal for timely intervention and improved outcomes.

Treatment & Management

Immediate management involves stabilization of airway, breathing, and circulation, followed by prompt initiation of antiepileptic drugs (AEDs), typically with benzodiazepines as first-line therapy for acute seizures or status epilepticus. Subsequent agents may include levetiracetam, phenytoin, valproate, or lacosamide, tailored to patient-specific factors and comorbidities. Addressing underlying systemic derangements—such as correcting metabolic imbalances, treating infections, and minimizing neurotoxic medications—is essential. In refractory cases, anesthetic agents and continuous EEG-guided titration may be required. Multidisciplinary collaboration between intensivists, neurologists, and pharmacists optimizes management.

Recent Advances / Emerging Therapies

Recent advances in seizure detection include the widespread adoption of continuous EEG monitoring, facilitating early identification and treatment of NCSE. Pharmacological innovations have yielded newer AEDs with improved safety profiles and reduced drug-drug interactions, critical in polypharmacy-prone ICU populations. Research into immunomodulatory therapies and neuroprotective agents is ongoing, with preliminary evidence suggesting potential benefit in select patient subsets. Artificial intelligence-assisted EEG interpretation and biomarker-driven risk stratification are emerging fields with promising implications for individualized care.

Guideline Recommendations

Contemporary guidelines, including those from the Neurocritical Care Society and the American Epilepsy Society, advocate for systematic risk assessment and early EEG monitoring in all patients with unexplained altered mental status or acute neurological deterioration after critical systemic injury. Prophylactic AED use is recommended in select conditions, such as severe TBI, but generally discouraged in the absence of documented seizures due to potential adverse effects. Therapy should be individualized, with regular reassessment for drug weaning and ongoing evaluation for secondary causes. Multidisciplinary protocols and regular education are emphasized to enhance detection and management of post-injury seizures.

Conclusion

Seizures represent a significant and potentially modifiable complication following critical systemic injuries, necessitating heightened clinical vigilance, prompt diagnosis, and evidence-based management. Advances in neurophysiological monitoring, pharmacotherapy, and multidisciplinary care are improving outcomes for affected patients. Ongoing research and adherence to guideline-driven protocols will further refine strategies to mitigate the seizure burden and optimize neurological recovery in the critically ill.